Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
100 participants
INTERVENTIONAL
2024-12-04
2027-02-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phenotypic and Functional Characterization of Neutrophils and Eosinophils in Severe Asthma Treated With Biotherapy
NCT05972213
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165
Follow-up of Mild Eosinophilic Asthma
NCT04650503
Non-coding RNAs Analysis of Eosinophil Subtypes in Asthma
NCT04542902
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated Eosinophils
NCT01366521
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Severe Asthma Patients : Biologic Naïves
Severe Asthma Patients : Biologic Naïves
Blood Punction
venous blood sampling
Severe Asthma Patients: Responders to Biologics
Severe Asthma Patients: Responders to Biologics
Blood Punction
venous blood sampling
Severe Asthma Patients: Non Responders to Biologics
Severe Asthma Patients: Non Responders to Biologics
Blood Punction
venous blood sampling
Mild asthmatics
Mild asthmatics
Blood Punction
venous blood sampling
Healthy Controls
Healthy Controls
Blood Punction
venous blood sampling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood Punction
venous blood sampling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signature of informed consent
* Affiliation with the French social security system
Exclusion Criteria
* Coexistence of a chronic eosinophilic inflammatory condition other than asthma
* Other respiratory conditions (cystic fibrosis, COPD, allergic bronchopulmonary aspergillosis, etc.)
* Treatment with corticosteroids within 10 days prior to inclusion
* Active smoking or a smoking history of more than 20 pack-years
* Pregnant women
* Legal incapacity or limited legal capacity
* Subject unlikely to cooperate with the study and/or with anticipated low cooperation as assessed by the investigator
* Subject without health insurance
* Subject currently in an exclusion period of another study or as indicated by the "national registry of volunteers."
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Besancon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024/877
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.